Natera Announces First Quarter 2021 Earnings Conference Call
Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA testing, will announce its first-quarter financial results on May 6, 2021, after market close. The company is set to host a conference call at 1:30 p.m. PT (4:30 p.m. ET) to discuss these results along with its business activities and future outlook.
Investors can participate via live dial-in or access the webcast for details. Natera focuses on advancing genetic testing services in women's health, oncology, and organ health, leveraging its CAP-accredited laboratories in Texas and California.
- Natera continues to lead in cell-free DNA testing, indicating strong market position.
- Scheduled earnings call shows commitment to transparency and investor engagement.
- None.
AUSTIN, Texas, April 29, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31, 2021, after the market close on May 6, 2021. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.
Earnings Conference Call Information:
Event: | Natera's First Quarter 2021 Financial Results Conference Call |
Date: | Thursday, May 6, 2021 |
Time: | 1:30 p.m. PT (4:30 p.m. ET) |
Live Dial-In: | (877) 823-0171, Domestic |
(617) 500-6932, International | |
Password: | 7557308 |
Webcast: |
A webcast replay will be available at investor.natera.com.
About Natera
Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.
Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Kate Stabrawa, Communications, Natera, Inc., pr@natera.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-announces-first-quarter-2021-earnings-conference-call-301279838.html
SOURCE Natera, Inc.
FAQ
When will Natera announce its first-quarter 2021 earnings results?
What time is Natera's earnings conference call scheduled?
How can I access Natera's earnings conference call?
What is Natera's focus regarding its genetic testing services?
